{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:29Z","timestamp":1787027369992,"version":"build-2736575974"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>\n                    Osteoclast is a specialized cell that originates from monocytic lineage, communicates closely with osteoblasts under physiological conditions, participates in bone modeling and re-modeling, contributes to calcium homeostasis and osteoimmunity. In pathological conditions, it is involved in many tumors such as giant cell bone tumor (osteoclastoma), aneurysmal bone cyst, osteosarcoma, and metastatic cancers, and it usually causes local spread and progression of the tumor, working against the host. Since osteoclasts play an active role in primary bone tumors and bone metastases, the use of anti-osteoclastic agents significantly reduces the mortality and morbidity rates of patients by preventing the progression and local spread of tumors. Osteoclasts also accompany undifferentiated carcinomas of many organs, especially pancreas, thyroid, bladder and ovary. Undifferentiated carcinomas rich in osteoclasts have osteoclastoma-like histology. In these organs, osteoclastoma-like histology may accompany epithelial carcinomas, and\n                    <jats:italic>de novo<\/jats:italic>\n                    , benign and borderline tumors. Mature and immature myeloid cells, including osteoclasts, play an active role in the tumor progression in primary and metastatic tumor microenvironment, in epithelial-mesenchymal transition (EMT), mesenchymal-epithelial-transition (MET), and cancer stem cell formation. Additionally, they are the most suitable candidates for cancer cells in cell fusion due to their evolutionary fusion capabilities. Myeloid features and markers (CD163, CD33, CD68 etc.) can be seen in metastatic cancer cells. Consequently, they provide metastatic cancer cells with motility, margination, transmigration, chemotaxis, phagocytosis, angiogenesis, matrix degradation, and resistance to chemotherapy. For these reasons, we think that the concept of Epithelial-Mesencyhmal-Myeloid-Transition (EMMT) will be more accurate than EMT for cancer cells with myeloid properties.\n                  <\/jats:p>","DOI":"10.3389\/pore.2021.609472","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T09:09:26Z","timestamp":1619773766000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition"],"prefix":"10.3389","volume":"27","author":[{"given":"Kemal","family":"Behzatoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"B1","first-page":"311","article-title":"Breast cancer metastasis","volume":"9","author":"Scully","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.semcancer.2012.03.007","article-title":"New insights into the mechanisms of organ-specific breast cancer metastasis","volume":"22","author":"Lorusso","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fendo.2019.00490","article-title":"The autophagy in osteoimmunology: self-eating, maintance, and beyond","volume":"10","author":"Xiao","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3389\/fimmu.2019.01408","article-title":"Immune function and diversty of osteoclasts in normal and pathological conditions","volume":"10","author":"Madel","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3389\/fimmu.2019.02595","article-title":"Editorial: advances im osteoimmunology","volume":"10","author":"Blin-Wakkach","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"720504","DOI":"10.1155\/2013\/720504","article-title":"The Interplay between the bone and the immune system","volume":"2013","author":"Mori","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: new insights","volume":"1","author":"Feng","year":"2013","journal-title":"Bone Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/bonekey.2013.214","article-title":"Vitamin D: calcium and bone homeostasis during evolution","volume":"3","author":"Boullion","year":"2014","journal-title":"Bonekey Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16116","DOI":"10.1038\/nmicrobiol.2016.116","article-title":"The physiology and habitat of the last universal common ancestor","volume":"1","author":"Weiss","year":"2016","journal-title":"Nat Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.immuni.2008.06.018","article-title":"The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator","volume":"29","author":"Hikosaka","year":"2008","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ni.3732","article-title":"Idendification sub epithelial mesenchymal cells that induce IgA and diversity gut microbiata","volume":"18","author":"Nagashima","year":"2017","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9089610","DOI":"10.1155\/2016\/9089610","article-title":"The alternative faces of macrophage generate osteoclasts","volume":"2016","author":"Lampiasi","year":"2016","journal-title":"Biomed Res Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fimmu.2017.00954","article-title":"Emerging roles of osteoclast in the modulation of bone microenvironment and immune suppression in multipl myeloma","volume":"8","author":"Mansour","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1159\/000489184","article-title":"Molecular regulation of bone metastasis pathogenesis","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/ar2297","article-title":"IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats","volume":"9","author":"Yago","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00780","DOI":"10.1016\/j.heliyon.2018.e00780","article-title":"Peripheral blood monocytes show increased osteoclast differentiation potential compared to bone marrow monocytes","volume":"4","author":"Kylm\u00e4oja","year":"2018","journal-title":"Heliyon"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e18689","DOI":"10.1371\/journal.pone.0018689","article-title":"The critical role of IL-34 in osteoclastogenesis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jcp.25220","article-title":"Different blood-borne human osteoclast precursors respond in distinct ways to IL-17A","volume":"231","author":"Sprangers","year":"2016","journal-title":"J Cel Physiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.v75.1.1.bloodjournal7511","article-title":"Colony-stimulating factor-1 receptor","volume":"75","author":"Sherr","year":"1990","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2010.132852","article-title":"Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression","volume":"69","author":"Heiland","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.4049\/jimmunol.0802091","article-title":"IL-27 abrogates receptor activator of NF-\u03baB Ligand-mediated osteoclastogenesis of human granulocyte-macrophage Colony-Forming unit cells through STAT1-Dependent inhibition of c-fos","volume":"183","author":"Furukawa","year":"2009","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s13287-019-1500-x","article-title":"Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-\u03baB and NFATc1 activation","volume":"10","author":"Wu","year":"2019","journal-title":"Stem Cel Res Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4078\/jrd.2016.23.3.148","article-title":"Pro-inflammatory cytokines modulating osteoclast differentiation and function","volume":"23","author":"Seong","year":"2016","journal-title":"J Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"004","DOI":"10.1016\/j.jbo.2018.10.004","article-title":"Metastatic bone disease: pathogenesis and therapeutic options: up-date on bone metastasis management","volume":"15","author":"D'Oronzo","year":"2019","journal-title":"J Bone Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/cancers10070218","article-title":"The osteoclast in bone metastasis: player and target","volume":"10","author":"Maurizi","year":"2018","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s0140-6736(00)49915-0","article-title":"The Distribution of secondary growths in cancer of the Breast","volume":"133","author":"Paget","year":"1889","journal-title":"The Lancet"},{"key":"B32","volume-title":"A treatise on tumours","author":"Ewing","year":"1928"},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","article-title":"Bone marrow cells in the 'pre-metastatic niche': within bone and beyond","volume":"25","author":"Kaplan","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/bf03032353","article-title":"Molecular pathology of tumor metastasis","volume":"7","author":"T\u00edm\u00e1r","year":"2001","journal-title":"Pathol Oncol Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00223-017-0365-1","article-title":"Osteomimicry: how the seed grows in the soil","volume":"102","author":"Rucci","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0092-8674(01)00599-2","article-title":"IKK\u03b1 Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development","volume":"107","author":"Cao","year":"2001","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5312\/wjo.v4.i4.178","article-title":"Role of RANKL\/RANK in primary and secondary breast cancer","volume":"4","author":"Yoneda","year":"2013","journal-title":"Wjo"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1158\/0008-5472.can-12-0044","article-title":"RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis","volume":"72","author":"Palafox","year":"2012","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/ijms17101764","article-title":"What Is breast in the bone?","volume":"17","author":"Shemanko","year":"2016","journal-title":"Ijms"},{"key":"B42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bone.2006.11.006","article-title":"DU145 human prostate cancer cells express functional receptor activator of NF\u03baB: new insights in the prostate cancer bone metastasis process","volume":"40","author":"Mori","year":"2007","journal-title":"Bone"},{"key":"B44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12253-012-9538-4","article-title":"Denosumab-A powerful RANKL inhibitor to stop lytic metastases and other bone loss actions by osteoclasts","volume":"18","author":"Kopper","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.critrevonc.2018.10.011","article-title":"RANK\/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment","volume":"133","author":"van Dam","year":"2019","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7150\/jca.8242","article-title":"Should EMT of cancer cells be understood as epithelial-myeloid transition?","volume":"5","author":"Schramm","year":"2014","journal-title":"J Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.7150\/jca.31364","article-title":"The epithelial-myeloid-transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for epithelial- mesenchymal-transition hypothesis (EMT)?","volume":"10","author":"Schramm","year":"2019","journal-title":"J Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bone.2012.10.002","article-title":"Giant cell tumor of bone: a basic science perspective","volume":"52","author":"Cowan","year":"2013","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.anndiagpath.2007.09.002","article-title":"Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India","volume":"12","author":"Gupta","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"B50","first-page":"225","volume-title":"Giant Cell Tumor (Osteoclastoma). Dahlin\u2019s Bone Tumors; General aspects and data on 10,165 Cases","author":"Unni","year":"2010"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s11999-008-0327-z","article-title":"Histogenetic characterization of giant cell tumor of bone","volume":"466","author":"Salerno","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2000","journal-title":"J Bone Miner Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4055\/cios.2012.4.2.107","article-title":"Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor","volume":"4","author":"Kim","year":"2012","journal-title":"Clin Orthop Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jbmr.531","article-title":"Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"27","author":"Chiu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1078\/0344-0338-00359","article-title":"Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH\/PTHrP receptor in osteoclast-like giant cells","volume":"199","author":"Nakashima","year":"2003","journal-title":"Pathol - Res Pract"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9681","DOI":"10.1007\/s13277-016-4867-7","article-title":"Biological characteristics of a novel giant cell tumor cell line derived from spine","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumor Biol"},{"key":"B58","unstructured":"anticorps monoclonal2015"},{"key":"B59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.ccr-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1746-1596-9-111","article-title":"Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab","volume":"9","author":"Hakozaki","year":"2014","journal-title":"Diagn Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/pas.0000000000000506","article-title":"Denosumab-treated giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.humpath.2017.02.008","article-title":"Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls","volume":"63","author":"Roitman","year":"2017","journal-title":"Hum Pathol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1359\/jbmr.2002.17.2.257","article-title":"Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor","volume":"17","author":"Kubota","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1475-2867-14-62","article-title":"Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma","volume":"14","author":"Fu","year":"2014","journal-title":"Cancer Cel Int"},{"key":"B66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00428-004-1113-2","article-title":"Differential gene expression in stromal cells of human giant cell tumor of bone","volume":"445","author":"Wuelling","year":"2004","journal-title":"Virchows Arch"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat Med"},{"key":"B68","first-page":"983","article-title":"The origin of the neoplastic stromal cell in giant cell tumor of bone","volume":"34","author":"Wuelling","year":"2003","journal-title":"Hum Pathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/PAS.0000000000001446","article-title":"Giant cell tumor of bone with cartilage matrix: a clinicopathologic study of 17 Cases","volume":"44","author":"Br\u010di\u0107","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B70","first-page":"894","article-title":"Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts","volume":"12","author":"Folpe","year":"1999","journal-title":"Mod Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5146\/tjpath.2014.01167","article-title":"Soft tissue giant cell tumor of low malignant potential of the neck: a case report and review of the literature","volume":"30","author":"Calli","year":"2014","journal-title":"Tjpath"},{"key":"B72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3748\/wjg.v21.i2.694","article-title":"locally advanced undifferentiated carcinoma with osteoclast-like giant cells of the pancreas","volume":"21","author":"Gao","year":"2015","journal-title":"Wjg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00000478-200604000-00010","article-title":"Giant cell tumor of the extrahepatic biliary tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with osteoclast-like giant cells","volume":"30","author":"Albores-Saavedra","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40792-019-0635-4","article-title":"Case of giant cell tumor of the breast, clinically suspected as malignant breast tumor","volume":"5","author":"Terada","year":"2019","journal-title":"Surg Case Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/1742-6413.70407","article-title":"Fine needle aspiration biopsy of an osteoclast-rich undifferentiated urothelial carcinoma: a cytology case report and review of the literature","volume":"7","author":"Bui","year":"2010","journal-title":"Cytojournal"},{"key":"B76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.anndiagpath.2007.06.009","article-title":"Osteoclastlike giant cell tumor of the salivary gland","volume":"13","author":"Fang","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jc.2011-2306","article-title":"An unusual giant cell tumor of the thyroid: case report and review of the literature","volume":"98","author":"Derbel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/0973-029x.185903","article-title":"Primary osteoclast-like giant cell tumor of parotid gland: a rare extraskeletal presentation with diagnostic challenges","volume":"20","author":"Singh","year":"2016","journal-title":"J Oral Maxillofac Pathol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0034-1385945","article-title":"Kasuistik: osteoklastischer riesenzelltumor der stimmlippe - eine sehr seltene Ursache f\u00fcr Heiserkeit","volume":"94","author":"Froboese","year":"2015","journal-title":"Laryngo-Rhino-Otol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2490-4-7","article-title":"Primary De Novo malignant giant cell tumor of kidney: a case report","volume":"4","author":"Kanthan","year":"2004","journal-title":"BMC Urol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41379-018-0012-z","article-title":"An expandet immunohistochemical profile os osteoclastic-rich undifferenriated carcinoma of the urinary bladder","volume":"31","author":"Priori","year":"2018","journal-title":"Mod Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/pas.0000000000000689","article-title":"undifferentiated carcinoma with osteoclastic giant cells of the pancreas","volume":"40","author":"Muraki","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.humpath.2018.07.027","article-title":"Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study","volume":"82","author":"Deeken-Draisey","year":"2018","journal-title":"Hum Pathol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4941","article-title":"Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma","volume":"243","author":"Luchini","year":"2017","journal-title":"J Pathol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/modpathol.3800521","article-title":"Osteoclast-rich undifferentiated carcinomas of the urinary tract","volume":"19","author":"Baydar","year":"2006","journal-title":"Mod Pathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.prp.2011.09.003","article-title":"Osteoclast-rich undifferentiated carcinoma of the urinary bladder: an immunohistochemical study","volume":"207","author":"Kawano","year":"2011","journal-title":"Pathol - Res Pract"},{"key":"B87","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1746-1596-4-48","article-title":"Giant cell tumor-like lesion of the urinary bladder: a report of two cases and literature review; giant cell tumor or undifferentiated carcinoma?","volume":"4","author":"Behzato\u011flu","year":"2009","journal-title":"Diagn Pathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/PAP.0b013e3181e4e348","article-title":"Osteoclast-rich undifferentiated carcinoma of the urinary bladder: is it really an entity?","volume":"17","author":"Behzatoglu","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3350\/cmh.2015.21.3.309","article-title":"Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: a case report","volume":"21","author":"Kim","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s004280050091","article-title":"Osteoclast-like giant cell tumour of the pancreas presenting as a pseudocyst-like lesion","volume":"431","author":"Oehler","year":"1997","journal-title":"Virchows Archiv"},{"key":"B91","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/pgp.0000000000000153","article-title":"Osteosarcoma as malignant mural nodule in ovarian mucinous neoplasms of intestinal Ttype","volume":"34","author":"McFarland","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000085283","article-title":"Osteoclast-like giant cell tumor of the pancreas associated with mucus-secreting adenocarcinoma. Case report and discussion of the histogenesis","volume":"5","author":"Nai","year":"2005","journal-title":"Pancreatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.prp.2008.11.006","article-title":"Undifferentiated pancreatic carcinoma with osteoclast-like giant cells: report of a case with osteochondroid differentiation","volume":"205","author":"Manduch","year":"2009","journal-title":"Pathol - Res Pract"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/pas.0b013e318067bca8","article-title":"Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution","volume":"31","author":"Bergmann","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1097\/00000478-200312000-00009","article-title":"Molecular Evidence of Anaplastic Transformation in Coexisting Well-Differentiated and Anaplastic Carcinomas of the Thyroid","volume":"27","author":"Hunt","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"B96","first-page":"560","article-title":"Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma","volume":"8","author":"Jung","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1078\/0344-0338-00044","article-title":"The Expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation","volume":"197","author":"Gaumann","year":"2001","journal-title":"Pathol - Res Pract"},{"key":"B98","first-page":"435","article-title":"Sarcoma-Like mural nodule in a borderline mucinous tumour of ovary","volume":"26","author":"Ahmed","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"B99","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.soc.2015.11.002","article-title":"Spectrum and classification of cystic neoplasms of the pancreas","volume":"25","author":"Greer","year":"2016","journal-title":"Surg Oncol Clin North America"},{"key":"B100","first-page":"308","article-title":"Multilocular cystadenoma of the liver with mural nodules","volume":"36","author":"Joseph","year":"1993","journal-title":"Indian J Pathol Microbiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00428-007-0479-3","article-title":"Primary retroperitoneal mucinous cystadenoma with sarcoma-like mural nodule","volume":"451","author":"Bakker","year":"2007","journal-title":"Virchows Arch"},{"key":"B102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/pgp.0b013e31825f7c41","article-title":"Primary retroperitoneal mucinous cystadenoma with a sarcoma-like mural nodule","volume":"32","author":"Demirel","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/path.4572","article-title":"Clonality analysis of combined brenner and mucinous tumours of the ovary reveals their monoclonal origin","volume":"237","author":"Wang","year":"2015","journal-title":"J Pathol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/s1470-2045(05)70466-6","article-title":"Tumour-cell fusion as a source of myeloid traits in cancer","volume":"6","author":"Pawelek","year":"2005","journal-title":"Lancet Oncol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1\u03b2 regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur J Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J Mol Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","article-title":"Controversies around epithelial-mesenchymal plasticity in cancer metastasis","volume":"19","author":"Williams","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"11766","DOI":"10.1038\/srep11766","article-title":"A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome","volume":"5","author":"Soundararajan","year":"2015","journal-title":"Sci Rep"},{"key":"B112","first-page":"4451","article-title":"The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma","volume":"31","author":"Chikaishi","year":"2011","journal-title":"Anticancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"14979","DOI":"10.1038\/ncomms14979","article-title":"Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade","volume":"8","author":"Ouzounova","year":"2017","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tcb.2007.09.004","article-title":"Cell fusion during development","volume":"17","author":"Oren-Suissa","year":"2007","journal-title":"Trends Cel Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nrc2272","article-title":"Cell-to-cell fusion as a link between Viruses and cancer","volume":"7","author":"Duelli","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B117","doi-asserted-by":"publisher","first-page":"108137","DOI":"10.1016\/j.abb.2019.108137","article-title":"Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt\/\u03b2-catenin signaling pathway","volume":"676","author":"Zhang","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/ijms17091587","article-title":"Cancer cell fusion: mechanisms slowly unravel","volume":"17","author":"Noubissi","year":"2016","journal-title":"Ijms"},{"key":"B119","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.2078","article-title":"Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?","volume":"211","author":"Andersen","year":"2007","journal-title":"J Pathol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e41942","DOI":"10.1371\/journal.pone.0041942","article-title":"Tumor associated macrophage \u00d7 cancer cell hybrids may acquire cancer stem cell properties in breast cancer","volume":"7","author":"Ding","year":"2012","journal-title":"PLoS One"},{"key":"B121","first-page":"321","article-title":"Giant cell tumor of bone","volume-title":"World Health Organization Classification of Tumours of Soft Tissue and Bone","author":"Athanasou","year":"2013"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.609472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T09:09:52Z","timestamp":1619773792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.609472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":121,"alternative-id":["10.3389\/pore.2021.609472"],"URL":"https:\/\/doi.org\/10.3389\/pore.2021.609472","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"article-number":"609472"}}